Proteomics and machine learning approaches reveal a set of prognostic markers for COVID-19 severity with drug repurposing potential K Suvarna, D Biswas, MGJ Pai, A Acharjee, R Bankar, V Palanivel, ... Frontiers in physiology 12, 652799, 2021 | 67 | 2021 |
A biotechnological approach for degradation of inhibitory compounds present in lignocellulosic biomass hydrolysate liquor using Bordetella sp. BTIITR B Singh, A Verma, PK Mandal, S Datta Chemical engineering journal 328, 519-526, 2017 | 45 | 2017 |
Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19 R Bankar, K Suvarna, S Ghantasala, A Banerjee, D Biswas, M Choudhury, ... Iscience 24 (3), 2021 | 34 | 2021 |
Recent advances in mass-spectrometry based proteomics software, tools and databases A Halder, A Verma, D Biswas, S Srivastava Drug Discovery Today: Technologies 39, 69-79, 2021 | 28 | 2021 |
Comprehensive workflow of mass spectrometry-based shotgun proteomics of tissue samples A Verma, V Kumar, S Ghantasala, S Mukherjee, S Srivastava JoVE (Journal of Visualized Experiments), e61786, 2021 | 10 | 2021 |
Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches A Mukherjee, A Verma, S Bihani, A Burli, K Mantri, S Srivastava Drug Discovery Today: Technologies 39, 1-12, 2021 | 7 | 2021 |
Integrative proteomic and pharmacological analysis of colon cancer reveals the classical lipogenic pathway with prognostic and therapeutic opportunities A Barpanda, D Biswas, A Verma, S Parihari, A Singh, S Kapoor, ... Journal of Proteome Research 22 (3), 871-884, 2023 | 5 | 2023 |
A proteogenomic approach to target neoantigens in solid tumors A Verma, A Halder, S Marathe, R Purwar, S Srivastava Expert Review of Proteomics 17 (11-12), 797-812, 2020 | 4 | 2020 |
A proteome-level view of brain tumors for a better understanding of novel diagnosis, prognosis, and therapy MGJ Pai, D Biswas, A Verma, S Srivastava Expert Review of Proteomics 20 (12), 381-395, 2023 | 1 | 2023 |
Identification of potential biomarkers in glioblastoma through omics technologies and big data analysis A Verma, A Halder, P Prakash, S Srivastava New Insights Into Glioblastoma, 33-54, 2023 | 1 | 2023 |
NGS technologies for detection of SARS-CoV-2 strains and mutations M Choudhury, A Verma, A Halder, A Acharjee Multi-Pronged Omics Technologies to Understand COVID-19, 21-37, 2022 | 1 | 2022 |
Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing A Verma, R Patel, A Mahale, RV Thorat, SL Rath, E Sridhar, A Moiyadi, ... OMICS: A Journal of Integrative Biology 28 (2), 59-75, 2024 | | 2024 |
Comprehensive proteomic investigation of high-grade and low-grade gliomas reveals pathways associated with cancer metastasis and candidate protein markers of therapeutic potential A Verma, A Bhat, E Sridhar, A Moiyadi, S Srivastava Authorea Preprints, 2023 | | 2023 |
Proteomic Investigation of COVID-19 Severity During the Tsunamic Second Wave in Mumbai S Rajoria, D Nair, K Suvarna, MGJ Pai, A Salkar, V Palanivel, A Verma, ... Application of Omic Techniques to Identify New Biomarkers and Drug Targets …, 2023 | | 2023 |
Insights into interactomics-driven drug repurposing to combat COVID-19 A Mukherjee, A Verma, A Burli, K Mantri, S Bihani Multi-Pronged Omics Technologies to Understand COVID-19, 169-188, 2022 | | 2022 |